- Home
- ADCT vs HVT Comparison
ADCT vs HVT Comparison
Compare ADCT & HVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- HVT
- Stock Information
- Founded
- ADCT 2011
- HVT 1885
- Country
- ADCT Switzerland
- HVT United States
- Employees
- ADCT N/A
- HVT N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- HVT Other Specialty Stores
- Sector
- ADCT Health Care
- HVT Consumer Discretionary
- Exchange
- ADCT Nasdaq
- HVT Nasdaq
- Market Cap
- ADCT 398.2M
- HVT 329.5M
- IPO Year
- ADCT 2020
- HVT N/A
- Fundamental
- Price
- ADCT $3.25
- HVT $23.39
- Analyst Decision
- ADCT Strong Buy
- HVT
- Analyst Count
- ADCT 6
- HVT 0
- Target Price
- ADCT $7.80
- HVT N/A
- AVG Volume (30 Days)
- ADCT 545.2K
- HVT 105.0K
- Earning Date
- ADCT 11-06-2025
- HVT 10-29-2025
- Dividend Yield
- ADCT N/A
- HVT 5.47%
- EPS Growth
- ADCT N/A
- HVT N/A
- EPS
- ADCT N/A
- HVT 1.17
- Revenue
- ADCT $77,246,000.00
- HVT $722,858,000.00
- Revenue This Year
- ADCT $13.10
- HVT $3.69
- Revenue Next Year
- ADCT $6.23
- HVT $8.33
- P/E Ratio
- ADCT N/A
- HVT $19.96
- Revenue Growth
- ADCT 15.73
- HVT N/A
- 52 Week Low
- ADCT $1.05
- HVT $17.01
- 52 Week High
- ADCT $3.97
- HVT $28.53
- Technical
- Relative Strength Index (RSI)
- ADCT 51.93
- HVT 54.82
- Support Level
- ADCT $3.15
- HVT $22.66
- Resistance Level
- ADCT $3.38
- HVT $24.34
- Average True Range (ATR)
- ADCT 0.18
- HVT 0.69
- MACD
- ADCT -0.02
- HVT -0.06
- Stochastic Oscillator
- ADCT 38.53
- HVT 53.86
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.